Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

ClinicalTrials.gov ID: NCT01039688

Public ClinicalTrials.gov record NCT01039688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 1:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Randomized, Double-blind Study Of The Efficacy And Safety Of 2 Doses Of Cp-690,550 Compared To Methotrexate In Methotrexate Navie Patients With Rheumatoid Arthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to compare the effectiveness of the experimental drug, CP-690,550, to methotrexate in preventing joint damage and improving symptoms of rheumatoid arthritis. This study will also compare the safety of CP-690,550 with methotrexate.

Study identification

NCT ID
NCT01039688
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
956 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2010 (Actual)
Primary completion
Mar 2013 (Actual)
Completion
Mar 2013 (Actual)
Last update posted
Apr 6, 2018

2010 – 2013

United States locations

U.S. sites
41
U.S. states
19
U.S. cities
28
Facility City State ZIP Site status
Catalina Pointe Clinical Research, Inc. Tucson Arizona 85704 —
Little Rock Diagnostic Clinic Little Rock Arkansas 72205 —
University of California San Diego Perlman Ambulatory Clinic La Jolla California 92037-0943 —
University of California San Diego Center for Innovative Therapy La Jolla California 92093 0943 —
Keck Hospital of USC, Lower Level Pharmacy Los Angeles California 90033 —
Keck Hospital of USC Los Angeles California 90033 —
USC Keck School of Medicine Los Angeles California 90033 —
University of California Los Angeles (UCLA) Los Angeles California 90095 —
Southeastern Arthritis Center Gainesville Florida 32607 —
Southeastern Imaging and Diagnostics Gainesville Florida 32607 —
Southeastern Integrated Medical, PL dba Florida Medical Research Gainesville Florida 32607 —
Center for Arthritis and Rheumatic Diseases Miami Florida 33173 —
Sarasota Arthritis Research Center Sarasota Florida 34239 —
West Broward Rheumatology Associates, Inc. Tamarac Florida 33321 —
Bernard F. Germain, MD Tampa Florida 33613 —
Burnette & Silverfield, MDS PLC Tampa Florida 33614 —
Diagnostic Rheumatology and Research, PC Indianapolis Indiana 46227 —
Medical Associates Clinic, PC Dubuque Iowa 52002 —
Louisiana State University Health Sciences New Orleans Louisiana 70115 —
The Center for Rheumatology and Bone Research Wheaton Maryland 20902 —
Clinical Pharmacology Study Group Worcester Massachusetts 01605 —
Physician Research Collaboration, LLC Lincoln Nebraska 68516 —
The Center for Rheumatology Albany New York 12206 —
AAIR Research Center Rochester New York 14618 —
PMG Research of Hickory, LLC Hickory North Carolina 28601 —
PMG Research of Hickory, LLC Hickory North Carolina 28602 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Clinical Research Center of Reading, LLP Wyomissing Pennsylvania 19610 —
Medical University of South Carolina - Rheumatology Charleston South Carolina 29425 —
Medical University of South Carolina Investigational Drug Services Charleston South Carolina 29425 —
Medical University of South Carolina Charleston South Carolina 29425 —
Arthritis Clinic Jackson Tennessee 38305 —
West Tennessee Research Institute Jackson Tennessee 38305 —
Austin Rheumatology Research Austin Texas 78705 —
Metroplex Clinical Research Center Dallas Texas 75231 —
University of North Texas Health Science Center at Fort Worth Fort Worth Texas 76107 —
Investigational Drug Service Seattle Washington 98101 —
Virginia Mason Medical Center Seattle Washington 98101 —
Mountain State Clinical Research Clarksburg West Virginia 26301 —
United Hospital Center (Imaging Only) Clarksburg West Virginia 26301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01039688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 6, 2018 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01039688 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →